Meeting
2017 ASCO Annual Meeting
Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP+IP DOC trial.
Authors
Ryoji Fukushima
Teikyo University, School of Medicine, Tokyo, Japan
Ryoji Fukushima , Hironori Ishigami , Hiroto Miwa , Motohiro Imano , Daisuke Kobayashi , Yasushi Tsuji , Akio Hidemura , Tetsuya Kusumoto , Takeshi Omori , Hiroshi Yabusaki , Norifumi Ohashi , Mitsuhiko Ota , Hironori Yamaguchi , Joji Kitayama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
UMIN000016469
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4039)
DOI
10.1200/JCO.2017.35.15_suppl.4039
Abstract #
4039
Poster Bd #
31
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Phase II study of intraperitoneal paclitaxel combined with S-1 plus cisplatin for gastric cancer with peritoneal metastasis: SP + IP PTX trial.
First Author: Daisuke Kobayashi
Poster
2016 ASCO Annual Meeting
Phase II study of intraperitoneal paclitaxel plus S-1/oxaliplatin for gastric cancer with peritoneal metastasis: SOX+IP PTX trial.
First Author: Yoshiyuki Fujiwara
Poster
2017 Gastrointestinal Cancers Symposium
Phase II study of intraperitoneal paclitaxel plus S-1/paclitaxel for gastric cancer with positive peritoneal cytology: CY-PHOENIX trial.
First Author: Masaki Aizawa
Poster
2016 ASCO Annual Meeting
Phase III study of intraperitoneal paclitaxel plus s-1/paclitaxel compared with s-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial.
First Author: Hironori Ishigami